Post-translational Regulation of FNIP1 Creates a Rheostat for the Molecular Chaperone Hsp90.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
29 01 2019
Historique:
received: 01 11 2018
revised: 12 12 2018
accepted: 04 01 2019
entrez: 31 1 2019
pubmed: 31 1 2019
medline: 14 3 2020
Statut: ppublish

Résumé

The molecular chaperone Hsp90 stabilizes and activates client proteins. Co-chaperones and post-translational modifications tightly regulate Hsp90 function and consequently lead to activation of clients. However, it is unclear whether this process occurs abruptly or gradually in the cellular context. We show that casein kinase-2 phosphorylation of the co-chaperone folliculin-interacting protein 1 (FNIP1) on priming serine-938 and subsequent relay phosphorylation on serine-939, 941, 946, and 948 promotes its gradual interaction with Hsp90. This leads to incremental inhibition of Hsp90 ATPase activity and gradual activation of both kinase and non-kinase clients. We further demonstrate that serine/threonine protein phosphatase 5 (PP5) dephosphorylates FNIP1, allowing the addition of O-GlcNAc (O-linked N-acetylglucosamine) to the priming serine-938. This process antagonizes phosphorylation of FNIP1, preventing its interaction with Hsp90, and consequently promotes FNIP1 lysine-1119 ubiquitination and proteasomal degradation. These findings provide a mechanism for gradual activation of the client proteins through intricate crosstalk of post-translational modifications of the co-chaperone FNIP1.

Identifiants

pubmed: 30699359
pii: S2211-1247(19)30027-0
doi: 10.1016/j.celrep.2019.01.018
pmc: PMC6370319
mid: NIHMS1519903
pii:
doi:

Substances chimiques

Carrier Proteins 0
FNIP1 protein, human 0
HSP90 Heat-Shock Proteins 0
Nuclear Proteins 0
Phosphoserine 17885-08-4
Casein Kinase II EC 2.7.11.1
Phosphoprotein Phosphatases EC 3.1.3.16
protein phosphatase 5 EC 3.1.3.16
Proteasome Endopeptidase Complex EC 3.4.25.1

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1344-1356.e5

Subventions

Organisme : CCR NIH HHS
ID : HHSN261200800001C
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261200800001E
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM124256
Pays : United States

Informations de copyright

Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Références

Mol Biol Cell. 1998 Nov;9(11):3071-83
pubmed: 9802897
Trends Biochem Sci. 2013 May;38(5):253-62
pubmed: 23507089
Methods Enzymol. 2010;484:471-93
pubmed: 21036246
Mol Cell. 2010 Feb 12;37(3):333-43
pubmed: 20159553
Am J Physiol Cell Physiol. 2012 Jun 15;302(12):C1786-96
pubmed: 22496241
EMBO J. 1998 Dec 1;17(23):6879-87
pubmed: 9843494
Mol Biol Cell. 2008 Dec;19(12):5249-58
pubmed: 18829866
Mol Cell Biol. 2004 Feb;24(4):1680-90
pubmed: 14749383
Glycobiology. 2017 Jun 8;:
pubmed: 28595377
Trends Biochem Sci. 2017 Oct;42(10):799-811
pubmed: 28784328
Gene. 2008 May 31;415(1-2):60-7
pubmed: 18403135
Mol Cell Biol. 1995 Jul;15(7):3917-25
pubmed: 7791797
Nucleic Acids Res. 2016 Jan 4;44(D1):D447-56
pubmed: 26527722
Biochim Biophys Acta. 2012 Mar;1823(3):668-73
pubmed: 21889547
Nat Commun. 2016 Jun 29;7:12037
pubmed: 27353360
Cell Rep. 2017 Nov 14;21(7):1883-1895
pubmed: 29141220
Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15552-7
pubmed: 17028174
Cell Mol Life Sci. 2002 Oct;59(10):1640-8
pubmed: 12475174
Science. 2016 Jun 24;352(6293):1542-7
pubmed: 27339980
Genes Dev. 1989 Oct;3(10):1590-601
pubmed: 2515114
Eukaryot Cell. 2005 May;4(5):849-60
pubmed: 15879519
Nat Rev Mol Cell Biol. 2017 Jun;18(6):345-360
pubmed: 28429788
J Proteomics. 2015 Apr 6;118:49-62
pubmed: 25449829
Mol Biol Cell. 2004 Nov;15(11):4787-97
pubmed: 15342786
Mol Biol Cell. 1992 Nov;3(11):1245-57
pubmed: 1457829
PLoS One. 2013 Nov 27;8(11):e80425
pubmed: 24312219
Cell Stress Chaperones. 2018 Jul;23(4):467-482
pubmed: 29392504
Nat Chem Biol. 2012 Jan 22;8(3):262-9
pubmed: 22267120
Nature. 1990 Nov 8;348(6297):166-8
pubmed: 2234079
Nat Struct Mol Biol. 2016 Nov;23(11):1020-1028
pubmed: 27723736
Mol Biosyst. 2015 Oct;11(10):2666-79
pubmed: 26211804
Nat Commun. 2018 Jan 17;9(1):265
pubmed: 29343704
EMBO J. 1998 Aug 17;17(16):4829-36
pubmed: 9707442
J Biol Chem. 2010 Dec 10;285(50):39096-107
pubmed: 20926391
Mol Cell. 2010 Aug 13;39(3):321-31
pubmed: 20705236
Mol Cell. 2011 Mar 18;41(6):672-81
pubmed: 21419342
Biochem J. 2016 Aug 15;473(16):2439-52
pubmed: 27515256
Mol Cell. 2017 Sep 21;67(6):947-961.e5
pubmed: 28890336
Cell. 2006 Nov 17;127(4):803-15
pubmed: 17110338
Mol Cell. 2014 Jan 23;53(2):317-29
pubmed: 24462205
Eukaryot Cell. 2006 Nov;5(11):1914-24
pubmed: 16950928
Eur J Biochem. 2003 Dec;270(23):4689-95
pubmed: 14622256
FEBS J. 2013 Mar;280(6):1381-96
pubmed: 23356585
Methods Mol Biol. 2018;1709:209-219
pubmed: 29177662
Trends Biochem Sci. 2018 Dec;43(12):935-937
pubmed: 30361061
Mol Microbiol. 2001 Feb;39(4):914-23
pubmed: 11251812
Hum Reprod. 2014 Jun;29(6):1292-303
pubmed: 24713123
Mol Cell Biol. 1993 Sep;13(9):5290-300
pubmed: 7689149
Essays Biochem. 2004;40:41-58
pubmed: 15242338

Auteurs

Rebecca A Sager (RA)

Department of Urology, SUNY Upstate Medical University, Syracuse, NY 13210, USA; Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University, Syracuse, NY 13210, USA; Upstate Cancer Center, SUNY Upstate Medical University, Syracuse, NY 13210, USA.

Mark R Woodford (MR)

Department of Urology, SUNY Upstate Medical University, Syracuse, NY 13210, USA; Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University, Syracuse, NY 13210, USA; Upstate Cancer Center, SUNY Upstate Medical University, Syracuse, NY 13210, USA.

Sarah J Backe (SJ)

Department of Urology, SUNY Upstate Medical University, Syracuse, NY 13210, USA; Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University, Syracuse, NY 13210, USA; Upstate Cancer Center, SUNY Upstate Medical University, Syracuse, NY 13210, USA.

Alan M Makedon (AM)

Department of Urology, SUNY Upstate Medical University, Syracuse, NY 13210, USA; Upstate Cancer Center, SUNY Upstate Medical University, Syracuse, NY 13210, USA.

Alexander J Baker-Williams (AJ)

Department of Urology, SUNY Upstate Medical University, Syracuse, NY 13210, USA; Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University, Syracuse, NY 13210, USA; Upstate Cancer Center, SUNY Upstate Medical University, Syracuse, NY 13210, USA.

Bryanna T DiGregorio (BT)

Department of Urology, SUNY Upstate Medical University, Syracuse, NY 13210, USA; Upstate Cancer Center, SUNY Upstate Medical University, Syracuse, NY 13210, USA.

David R Loiselle (DR)

Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA.

Timothy A Haystead (TA)

Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA.

Natasha E Zachara (NE)

Department of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

Chrisostomos Prodromou (C)

Genome Damage and Stability Centre, University of Sussex, Brighton BN1 9RQ, UK.

Dimitra Bourboulia (D)

Department of Urology, SUNY Upstate Medical University, Syracuse, NY 13210, USA; Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University, Syracuse, NY 13210, USA; Upstate Cancer Center, SUNY Upstate Medical University, Syracuse, NY 13210, USA.

Laura S Schmidt (LS)

Basic Science Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.

W Marston Linehan (WM)

Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.

Gennady Bratslavsky (G)

Department of Urology, SUNY Upstate Medical University, Syracuse, NY 13210, USA; Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University, Syracuse, NY 13210, USA; Upstate Cancer Center, SUNY Upstate Medical University, Syracuse, NY 13210, USA.

Mehdi Mollapour (M)

Department of Urology, SUNY Upstate Medical University, Syracuse, NY 13210, USA; Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University, Syracuse, NY 13210, USA; Upstate Cancer Center, SUNY Upstate Medical University, Syracuse, NY 13210, USA. Electronic address: mollapom@upstate.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH